- Home
- IPDN vs APVO Comparison
IPDN vs APVO Comparison
Compare IPDN & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- APVO
- Stock Information
- Founded
- IPDN 2003
- APVO 2016
- Country
- IPDN United States
- APVO United States
- Employees
- IPDN N/A
- APVO N/A
- Industry
- IPDN EDP Services
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- APVO Health Care
- Exchange
- IPDN Nasdaq
- APVO Nasdaq
- Market Cap
- IPDN 4.3M
- APVO 4.1M
- IPO Year
- IPDN 2013
- APVO N/A
- Fundamental
- Price
- IPDN $1.68
- APVO $3.23
- Analyst Decision
- IPDN
- APVO Strong Buy
- Analyst Count
- IPDN 0
- APVO 1
- Target Price
- IPDN N/A
- APVO $5,920.00
- AVG Volume (30 Days)
- IPDN 26.4K
- APVO 6.6M
- Earning Date
- IPDN 08-12-2025
- APVO 08-07-2025
- Dividend Yield
- IPDN N/A
- APVO N/A
- EPS Growth
- IPDN N/A
- APVO N/A
- EPS
- IPDN N/A
- APVO N/A
- Revenue
- IPDN $6,508,349.00
- APVO N/A
- Revenue This Year
- IPDN N/A
- APVO N/A
- Revenue Next Year
- IPDN N/A
- APVO N/A
- P/E Ratio
- IPDN N/A
- APVO N/A
- Revenue Growth
- IPDN N/A
- APVO N/A
- 52 Week Low
- IPDN $0.97
- APVO $2.81
- 52 Week High
- IPDN $11.20
- APVO $485.37
- Technical
- Relative Strength Index (RSI)
- IPDN 48.27
- APVO 34.28
- Support Level
- IPDN $1.34
- APVO $2.81
- Resistance Level
- IPDN $1.80
- APVO $13.11
- Average True Range (ATR)
- IPDN 0.13
- APVO 1.10
- MACD
- IPDN -0.02
- APVO 0.30
- Stochastic Oscillator
- IPDN 41.51
- APVO 4.08
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.